The DOI matches its Crossref record; 223 of the 230 references it cites were found in a registry or an index.
11-Oxygenated androgens in health and disease
Open accessAbstract
The adrenal gland is a source of sex steroid precursors, and its activity is particularly relevant during fetal development and adrenarche. Following puberty, the synthesis of androgens by the adrenal gland has been considered of little physiologic importance. Dehydroepiandrosterone (DHEA) and its sulfate, DHEAS, are the major adrenal androgen precursors, but they are biologically inactive. The second most abundant unconjugated androgen produced by the human adrenals is 11β-hydroxyandrostenedione (11OHA4). 11-Ketotestosterone, a downstream metabolite of 11OHA4 (which is mostly produced in peripheral tissues), and its 5α-reduced product, 11-ketodihydrotestosterone, are bioactive androgens, with potencies equivalent to those of testosterone and dihydrotestosterone. These adrenal-derived androgens all share an oxygen atom on carbon 11, so we have collectively termed them 11-oxyandrogens. Over the past decade, these androgens have emerged as major components of several disorders of androgen excess, such as congenital adrenal hyperplasia, premature adrenarche and polycystic ovary syndrome, as well as in androgen-dependent tumours, such as castration-resistant prostate cancer. Moreover, in contrast to the more extensively studied, traditional androgens, circulating concentrations of 11-oxyandrogens do not demonstrate an age-dependent decline. This Review focuses on the rapidly expanding knowledge regarding the implications of 11-oxyandrogens in human physiology and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Adrenalspecific metabolites such as 21-deoxycortisol (387) and 11-oxygenated androgens (86) may provide more direct evidence for adrenal androgen production in CAH.”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [86]
In the citing paper
“These under-recognized 11-oxygenated adrenal metabolites are bioactive, dominant steroids in CAH15,20,49,50.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Scher, H. I., Fizazi, K., Saad, F., Taplin, M.-E., Sternberg, C. N., Miller, K., de Wit, R., Mulders, P., Chi, K. N., Shore, N. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207506 · Cited by 4,586
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Ryan, C. J., Smith, M. R., de Bono, J. S., Molina, A., Logothetis, C. J., de Souza, P., Fizazi, K., Mainwaring, P., Piulats, J. M., Ng, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209096 · Cited by 2,796
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationMen at risk: occupation and male infertility.
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Heidenreich, A., Bastian, P. J., Joaquim Bellmunt, B., Bolla, M., Joniau, S., van der Kwast, T., Mason, M., Matveev, V., Wiegel, T., Zattoni, F., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.11.002 · Cited by 1,869
Research works printed but not linked: 2
- Thomas, J. L., Myers, R. P. & Strickler, R. C. Human placental 3β-hydroxy-5-ene-steroid dehydrogenase and steroid 5/4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes. J. Steroid Biochem. 33, 209–217 (1989). · DOI · Paper page
- Fluck, C. E., Miller, W. L. & Auchus, R. J. The 17,20-lyase activity of cytochrome p450c17 from human fetal testis favors the Δ5 steroidogenic pathway. J. Clin. Endocrinol. Metab. 88, 3762–3766 (2003). · DOI · Paper page
Cited by
Sorted by citations
Items 201–216 of 216
Suzuki, E., Sawano, K., Kuroki, Y., Dateki, S., Nagasaki, K., & Fukami, M. (2026) · Molecular Syndromology · doi:10.1159/000553259
Reproductive and fertility challenges in adolescents with congenital adrenal hyperplasia
Tschaidse, L., Auer, M. K., Nowotny, H. F., & Reisch, N. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1878713
Expanding the Measurement Space of Ion Mobility-Mass Spectrometry Using Chemical Derivatizations
Fernandez, S., Acateca, A., Garrison, B. B., Sabatini, H. M., & Chouinard, C. D. (2026) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.6c00210
Forslund, M., Melin, J. M., Joham, A. E., Piltonen, T., Rees, A., & Teede, H. J. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70156 · Cited by 1
Wang, Y., Wang, T., Xi, Y., Wang, Y., Bai, Y., & Zhang, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1918543
HogenEsch, E., & Huddleston, H. G. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.08.1133
Endocrine Evaluation of Hyperandrogenism in Women
Grennan, K., & Chang, A. Y. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.07.005
Androgen profiles in full-term maternal-placental-fetal units
Koga, N., Fukui, Y., Doi, H., Aramaki, M., Yamamoto, H., Motomura, K., Wada, S., Matsumoto, K., Miyashiro, Y., Hattori, A., et al. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107123
Szklarz, M., Wołos-Kłosowicz, K., Szulc, J., Górny, J. M., & Matuszewski, W. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00364-8
Dynamic Metal–Organic Tweezer Enables High-Resolution Nanopore Analysis of Steroid Hormones
Yang, L., Guan, M.-X., Xu, Y.-Z., Zhao, J.-N., Yin, Y., Cui, Y.-Y., Xu, B., Lai, W., & Gu, Z. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c12576
Pinna, M., Tomaselli, A., Ferrari, D., Minnetti, M., Gianfrilli, D., Giannetta, E., Pozza, C., Isidori, P., Barbagallo, F., & Pofi, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1943976
Lundholm, K. R., Satterfield, B. C., Banks, S., Liu, P. Y., Thambiliya, C. J. K. N., Hurtado‐Alvarado, G., Greer, A. J., Muck, R. A., Layton, M. E., Du, D., et al. (2026) · Current Sleep Medicine Reports · doi:10.1007/s40675-026-00404-9
Schumacher, M., & Ghoumari, A. M. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101293
Baets, H. D., Reyns, T., Fiers, T., Cools, M., & Stove, C. P. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.122947
Sex differences in testosterone and obesity
Komai, S., Tsutsumi, T., & Tsuchiya, K. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1992734
Heráček, J., Gaduš, L., Horenitzky, M., Novàkovâ, M., Škodová, T., Kolátorová, L., Varausova, A., Lukášková, A., & Vítků, J. (2026) · The Prostate · doi:10.1002/pros.70273
Metadata
- Authors
- Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Turcu, Adina F.
- Venue
- Nature Reviews Endocrinology
- Published
- 2020-03-16
- Volume
- 16
- Issue
- 5
- Pages
- 284-296
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- PMC
- PMC7881526
- OpenAlex
- W3010961934
- Cited by
- 217
- References
- 230
- Citations by year
- 2026: 48 · 2025: 39 · 2024: 36 · 2023: 30 · 2022: 29 · 2021: 29 · 2020: 6
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM086596)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK109116, R01DK069950, R01DK043140)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- adrenal androgens, 11β-hydroxyandrostenedione, 11-ketotestosterone, dehydroepiandrosterone, dehydroepiandrosterone sulfate, congenital adrenal hyperplasia, premature adrenarche, polycystic ovary syndrome, castration-resistant prostate cancer, adrenal steroidogenesis, fetal development, adrenarche
- MeSH terms
- Adrenal Glands, Adrenal Hyperplasia, Congenital, Androgens, Endocrine System Diseases, Female, Humans, Male, Oxygen, Polycystic Ovary Syndrome, Prostatic Neoplasms, Puberty, Precocious
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
